Maplelane Capital’s Acacia Research ACTG Stock Holding History

Maplelane Capital’s Portfolio ACTG Stock Details ACTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-400,000	Closed	-$3.51M	–	86
2015 Q2	$3.51M	Sell	400,000 -200,000	-33%	-$2.05M	0.12%	100
2015 Q1	$6.42M	Buy	+600,000	New	+$7.83M	0.21%	99

Other funds holding ACTG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

RFC

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Maplelane Capital's ACTG Position: Q3 2015 in Review

Maplelane Capital sold out of Acacia Research (ACTG) in Q3 2015, closing a stake of 15,001 shares — an estimated $132K sold.

Maplelane Capital first reported a position in ACTG in Q1 2015 and held it in 2 quarters. The position peaked at $132K in Q2 2015. 108 funds tracked by Wall St. Rank hold ACTG as of Q3 2015.

Maplelane Capital reported no remaining Acacia Research position as of Q3 2015 after selling out during the quarter.
Maplelane Capital sold 15,001 Acacia Research shares in Q3 2015, an estimated $132K.
Maplelane Capital first reported a position in Acacia Research in Q1 2015 and held it in 2 quarters.
Maplelane Capital's Acacia Research position peaked at $132K in Q2 2015.
108 funds tracked by Wall St. Rank held Acacia Research as of Q3 2015.

Based on Maplelane Capital's 13F filing for Q3 2015, filed 16 Nov 2015.